Using a special stent to treat benign duodenal strictures
Official title: An Exploratory Clinical Study of Double Pig Tail Stent-assisted Fixation of Fully Covered Metal Stents for the Treatment of Benign Duodenal Strictures
Run by Jinling Hospital, China · NCT06736301 · Data updated 2026-11-12
This study is testing a special stent to see if it can help people with benign duodenal strictures feel better by keeping the narrowed area open and preventing the stent from moving out of place.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 75 Years |
| Sex | All |
| Enrollment | 5 (estimated) |
| Sponsor | Jinling Hospital, China Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | December 15, 2024 |
| Main results expected | November 30, 2027 |
| Study ends | November 30, 2027 |
| Registry record updated | March 10, 2025 |
| Trial ID | NCT06736301 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients under 75 years old with diagnosed benign duodenal strictures who have experienced symptoms of upper gastrointestinal obstruction and have not responded to multiple balloon dilations.
✕Probably not a fit
Patients with gastrointestinal perforation, malignant strictures, or severe comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the use of a double pig-tail stent to assist in the fixation of fully-covered metal stents for patients suffering from benign duodenal strictures. The approach aims to minimize stent displacement and ensure effective expansion of the narrowed duodenal area, thereby alleviating symptoms associated with upper gastrointestinal obstruction. The study will evaluate both the safety and efficacy of this method, providing insights into its long-term effectiveness for treating this condition.
Why it matters
Potential benefit: If successful, this approach could significantly improve symptom relief and quality of life for patients with benign duodenal strictures.
How similar studies have gone: While this specific approach is novel, similar studies using stent-assisted techniques have shown promise in managing gastrointestinal strictures.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The subjects voluntarily signed the informed consent form for this trial; 2. Patients diagnosed with benign duodenal stricture; 3. Symptoms of upper gastrointestinal obstruction, such as nausea, vomiting, abdominal pain, or changes in bowel habits, occurring before admission or during hospitalization; 4. Patients with refractory strictures who have failed multiple balloon dilations; 5. Age \< 75 years. Exclusion Criteria: 1. Gastrointestinal perforation; 2. Distal small bowel obstruction or multiple segments of small bowel obstruction; 3. Coagulation disorders; 4. Strictures or obstructions caused by malignant tumors; 5. Severe comorbidities involving the heart, brain, lungs, kidneys, etc.
Where it's running
-
Fully Covered Metal Stents
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Changqing Sun
- Email: 18851675250@163.com
- Phone: 18851675250
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brown fat activity after cold exposure measured by PET/CT in healthy people and those with metabolic conditions
This study tests how brown adipose tissue responds to cold exposure using PET/CT in adults aged 18-40, including some with diabetes or high cholesterol.
-
Peg IFNα-2b plus targeted immunotherapy for unresectable HBV-related HCC
This study tests whether adding pegylated interferon alpha-2b to targeted immunotherapy can help patients with unresectable HBV-related liver cancer stay or improve beyond standard nucleoside therapy.
-
Perioperative UDCA to Protect Kidney Function in Partial Nephrectomy
This study tests whether giving ursodeoxycholic acid around surgery can help protect kidney function in adults having partial nephrectomy for kidney tumors.
-
CD70-Targeted Imaging-Guided Pause of Therapy in Metastatic Clear Cell RCC
This study tests whether patients with metastatic clear cell RCC who respond to first-line PD-1/PD-L1 inhibitors plus VEGFR-TKI can safely pause treatment guided by CD70-targeted Immuno-PET/CT imaging.
-
Gut microbiota modulation to retry immunotherapy in advanced kidney cancer
This trial tests whether changing gut bacteria can help people with advanced renal cell carcinoma respond again to immunotherapy after resistance.
-
Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer
This study looks at whether surgery improves survival for people with localized small cell esophageal cancer compared with non-surgical treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.